ARTICLE | Clinical News
MPL immunomodulator data
October 31, 1994 8:00 AM UTC
The Hamilton, Mont., company announced Phase I results showing that two- to three-fold higher antibody titers followed use of its compound compared to other adjuvants.
The rgp120 HIV envelope vaccine, a Chiron Corp. protein, was given with seven different adjuvants to healthy volunteers. As reported at the International Conference on Mucosal Immunization, Genetic Approaches and Adjuvants in Rockville, Md., the higher titers were observed after two doses of the agent plus alum in liposomes. Higher titers also were seen using the SAF/2 adjuvant. ...